EcoDrugPlus

Cyclin Dependent Kinase 2

Ensembl ID : ENSPEMG00000009789
Gene Symbol: CDK2
3 Cross references
202 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSPEMG00000008062
Gene Symbol: CDK5
3 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSPEMG00000015977
Gene Symbol: CDK6
3 Cross references
198 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSPEMG00000001737
Gene Symbol: CDK7
3 Cross references
213 Possible Orthologues:

Cyclin-Dependent Kinase 9 (Cdc2-Related Kinase)

Ensembl ID : ENSPEMG00000010417
Gene Symbol: CDK9
1 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSPEMG00000023120
Gene Symbol: CYSLTR1
1 Cross references
177 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSPEMG00000024850
Gene Symbol: CDA
3 Cross references
224 Possible Orthologues:

Cytochrome P450 26a1

Ensembl ID : ENSPEMG00000013143
Gene Symbol: LOC102911269
3 Cross references
207 Possible Orthologues:

Cytochrome P450 3a13-Like

Ensembl ID : ENSPEMG00000024683
Gene Symbol: LOC102903813
2 Cross references
287 Possible Orthologues:

Cytochrome P450 3a6-Like

Ensembl ID : ENSPEMG00000027722
Gene Symbol: LOC102919158
2 Cross references
287 Possible Orthologues:

Cytochrome P450 3a9-Like

Ensembl ID : ENSPEMG00000024220
Gene Symbol: LOC102913063
2 Cross references
304 Possible Orthologues:

Dihydrofolate Reductase

Ensembl ID : ENSPEMG00000029212
Gene Symbol: DHFR
1 Cross references
353 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).